Drug recall D-1428-2014
Product
Fosphenytoin Sodium Injection, USP, 100 mg PE/2 mL (50 mg PE/mL) (PE= phenytoin sodium equivalents) 2 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-02
Reason for recall
Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.
Lots and codes
Lot # 6003850; 04/14 6003926; 05/14 6004052; 05/14 6004053; 05/14 6004093; 06/14 6004094; 06/14 6004199; 07/14 6004200; 07/14 6004509; 08/14 6004510; 08/14 6004661; 09/14 6005157; 11/14 6005158; 11/14 6005197; 11/14 6005198; 11/14 6005446; 01/15 6005447; 01/15 6005702; 03/15 6005703; 03/15 6005790; 03/15 6005791; 03/15 6006005; 05/15 6006006; 05/15 6006091; 05/15 6006211; 06/15 6006212; 06/15 6006396; 07/15 6006397; 07/15
Recall details
- Recalling firm
- Fresenius Kabi USA, LLC, Melrose Park, IL
- Quantity
- 2,070,500 vials
- Distribution
- Nationwide and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 2, 2014
- Terminated
- May 24, 2016
Related products
- Fosphenytoin – drug information
- NDC 63323-403 Fosphenytoin · Fosphenytoin Sodium 50 mg/mL · Fresenius Kabi USA, LLC